Back to News
May 6, 2026 4:00 PM

Why Novavax Stock Is Trading Higher On Wednesday?

Novavax Inc. (NASDAQ:NVAX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter financial results.

Novavax (NVAX) Q1 2026 Earnings Date And Key Catalyst

The COVID-19 vaccine maker reported quarterly sales of $139.51 million, beating the $78.32 million estimate.

The company reported a net loss of $9 million, compared to net income of $519 million a year ago.

First quarter of 2025 net income benefited from $603 million of non-cash sales related to the close-out of two APA agreements.  

Read Also:

Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy

Balance Sheet Strengthened With Credit Facility

Cash, cash equivalents, marketable securities, and restricted cash were $795 million.

In February 2026, Novavax announced a $330 million credit facility with MidCap Financial. The credit facility was put in place to further strengthen its balance sheet and provide access to non-dilutive capital as Novavax advances its growth strategy.

Strategic Partnerships Drive Long-Term Growth Outlook

During